Omeprazole 40 MG / sodium bicarbonate 1680 MG Powder for Oral Suspension — RxCUI 753557
RxNorm drug concept · Semantic clinical drug
RxCUI 753557
Semantic clinical drug · SCD
● Current RxNorm concept 13 FDA products
15 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI753557
Official nameOmeprazole 40 MG / sodium bicarbonate 1680 MG Powder for Oral Suspension
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asOmeprazole 40 MG / NaHCO3 1680 MG Powder for Oral Suspension
FDA products mapped13
Package NDCs mapped15
Reported Medicaid activity (SDUD)11,843 prescriptions · 9 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Sodium Bicarbonate: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Sodium bicarbonate antacids work fast for occasional heartburn, but they're not meant for daily long-term use on your own. Most labels say not to use the maximum dose for more than...
- Can I use this for my heartburn every day?
- The active ingredient is the same — sodium bicarbonate. Products like Arm and Hammer Baking Soda are actually FDA-labeled for both antacid use and skin soaks or compresses for irri...
- Is baking soda from the kitchen the same as these antacid products?
🕸️ Concept Web — How Omeprazole 40 MG / sodium bicarbonate 1680 MG Po... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Omeprazole 40 MG / sodium bicarbonate 1680 MG Powder for Oral Suspension
RxCUI 753557 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 3
The active substance itself — no strength, form, or brand attached yet.
-
Omeprazole
7646IN -
Sodium bicarbonate
36676IN -
Omeprazole / sodium bicarbonate
617777MIN
-
Omeprazole
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Zegerid Reformulated Aug 2006
646341BN
-
Zegerid Reformulated Aug 2006
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Omeprazole / sodium bicarbonate Powder for Oral Suspension
1855340SCDF -
Omeprazole / sodium bicarbonate Oral Powder Product
1855339SCDG -
Omeprazole / sodium bicarbonate Oral Product
1161024SCDG -
Omeprazole / sodium bicarbonate Powder for Oral Suspension [Zegerid Reformulated Aug 2006]
1855343SBDF -
Zegerid Reformulated Aug 2006 Oral Powder Product
1855344SBDG -
Zegerid Reformulated Aug 2006 Oral Product
1187228SBDG -
Powder for Oral Suspension
1540456DF -
Oral Powder Product
1294711DFG - +1 more in this family
-
Omeprazole / sodium bicarbonate Powder for Oral Suspension
-
Clinical & branded drugs 4
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Omeprazole 40 MG
317451SCDC -
Sodium bicarbonate 1680 MG
1855338SCDC -
Omeprazole 40 MG / sodium bicarbonate 1680 MG Powder for Oral Suspension [Zegerid Reformulated Aug 2006]
753601SBD -
Omeprazole 40 MG / sodium bicarbonate 1680 MG [Zegerid Reformulated Aug 2006]
1855347SBDC
-
Omeprazole 40 MG
Showing up to 8 concepts per family — 16 of 17 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Omeprazole 40 MG
SCDC · 317451 -
Sodium bicarbonate 1680 MG
SCDC · 1855338 -
Omeprazole / sodium bicarbonate Powder for Oral Suspension
SCDF · 1855340 -
Omeprazole / sodium bicarbonate Oral Powder Product
SCDG · 1855339 -
Omeprazole / sodium bicarbonate Oral Product
SCDG · 1161024
Brand-Name Concepts
-
Omeprazole 40 MG / sodium bicarbonate 1680 MG Powder for Oral Suspension [Zegerid Reformulated Aug 2006]
SBD · 753601 -
Omeprazole 40 MG / sodium bicarbonate 1680 MG [Zegerid Reformulated Aug 2006]
SBDC · 1855347 -
Omeprazole / sodium bicarbonate Powder for Oral Suspension [Zegerid Reformulated Aug 2006]
SBDF · 1855343 -
Zegerid Reformulated Aug 2006 Oral Powder Product
SBDG · 1855344 -
Zegerid Reformulated Aug 2006 Oral Product
SBDG · 1187228 -
Zegerid Reformulated Aug 2006
BN · 646341
📦 FDA Products & Package NDCs
13 products · 15 package NDCs
15 package NDCs map to RxCUI 753557 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 27241-0029-31 | 30 FOR SUSPENSION in 1 CARTON (27241-029-31) | Omeprazole and Sodium Bicarbonate | Ajanta Pharma USA Inc. | 2016-07-27 |
| 27241-0029-62 | 1 FOR SUSPENSION in 1 PACKET (27241-029-62) | Omeprazole and Sodium Bicarbonate | Ajanta Pharma USA Inc. | 2016-07-27 |
| 27241-0030-31 | 30 FOR SUSPENSION in 1 CARTON (27241-030-31) | Omeprazole and Sodium Bicarbonate | Ajanta Pharma USA Inc. | 2016-07-27 |
| 27241-0030-62 | 1 FOR SUSPENSION in 1 PACKET (27241-030-62) | Omeprazole and Sodium Bicarbonate | Ajanta Pharma USA Inc. | 2016-07-27 |
| 64380-0182-02 | 30 POUCH in 1 CARTON (64380-182-02) / 20 mg in 1 POUCH (643... | Omeprazole/Sodium Bicarbonate | Strides Pharma Science Limited | 2022-10-01 |
| 64380-0183-02 | 30 POUCH in 1 CARTON (64380-183-02) / 40 mg in 1 POUCH (643... | Omeprazole/Sodium Bicarbonate | Strides Pharma Science Limited | 2022-10-01 |
| 68012-0054-03 | 3 PACKET in 1 CARTON (68012-054-03) / 1 POWDER, FOR SUSPENS... | ZEGERID | Santarus, Inc.. | 2014-06-15 |
| 68012-0102-30 | 30 CAPSULE in 1 BOTTLE (68012-102-30) | ZEGERID | Santarus, Inc.. | 2006-02-27 |
| 68012-0104-05 | 5 CAPSULE in 1 BOTTLE (68012-104-05) | ZEGERID | Santarus, Inc.. | 2006-02-27 |
| 68012-0104-30 | 30 CAPSULE in 1 BOTTLE (68012-104-30) | ZEGERID | Santarus, Inc.. | 2006-02-27 |
| 68682-0102-30 | 30 CAPSULE in 1 BOTTLE (68682-102-30) | Omeprazole and Sodium Bicarbonate | Oceanside Pharmaceuticals | 2006-02-27 |
| 68682-0104-30 | 30 CAPSULE in 1 BOTTLE (68682-104-30) | Omeprazole and Sodium Bicarbonate | Oceanside Pharmaceuticals | 2007-02-27 |
| 68682-0990-30 | 30 PACKET in 1 CARTON (68682-990-30) / 1 POWDER, FOR SUSPEN... | Omeprazole and Sodium Bicarbonate | Oceanside Pharmaceuticals | 2004-06-15 |
| 70954-0797-20 | 30 PACKET in 1 CARTON (70954-797-20) / 1 POWDER, FOR SUSPEN... | Omeprazole and Sodium Bicarbonate | ANI Pharmaceuticals, Inc. | 2026-01-15 |
| 70954-0798-20 | 30 PACKET in 1 CARTON (70954-798-20) / 1 POWDER, FOR SUSPEN... | Omeprazole and Sodium Bicarbonate | ANI Pharmaceuticals, Inc. | 2026-01-15 |
Observed labelers:
Ajanta Pharma USA Inc. (4) ·
Santarus, Inc.. (4) ·
Oceanside Pharmaceuticals (3) ·
ANI Pharmaceuticals, Inc. (2) ·
Strides Pharma Science Limited (2)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.